SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-20-004686
Filing Date
2020-02-14
Accepted
2020-02-14 06:04:12
Documents
4
Effectiveness Date
2020-02-14

Document Format Files

Seq Description Document Type Size
1 S-8 rare-s8.htm S-8 84945
2 EX-5.1 rare-ex51_6.htm EX-5.1 10858
3 EX-23.1 rare-ex231_7.htm EX-23.1 2627
4 GRAPHIC ged4nvvvksst000001.jpg GRAPHIC 4841
  Complete submission text file 0001564590-20-004686.txt   106216
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-236428 | Film No.: 20613504
SIC: 2834 Pharmaceutical Preparations